Department of Urology, All India Institute of Medical Sciences (AIIMS) Jammu, has commenced advanced endourological services, ...
TipRanks on MSN
Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors
Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
Woman's World on MSN
Blood in your urine? 5 bladder cancer symptoms you should never ignore
Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being ...
enGene Holdings Inc. has surged after reporting a 62% six-month CR rate in its pivotal Phase 2 NMIBC trial. ENGN’s DDX gene delivery platform enables localized, multi-gene non-viral therapies, aiming ...
Urology experts often use a transurethral resection of bladder tumor (TURBT) to find out if someone has bladder cancer. They can then determine whether the cancer has spread into the muscle. It is ...
Providing surgeons feedback and education on their performance significantly improved the quality of bladder cancer operations, finds a new clinical trial led by researchers at UCL, UCLH and the ...
Joshua J. Meeks, MD, PhD, discussed the emerging role of ctDNA in guiding adjuvant and neoadjuvant strategies in patients with bladder cancer. Meeks began by highlighting results from the phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback